AthemBio is developing technology to isolate and purify therapeutic antibodies to treat COVID-19 and other pathogenic outbreaks.
Employment range in NC
Primary site activity
All company activities
Products on market
CORIg™: Single-use continuous flow centrifugation, diverse applications; machroS™: purifies immunoglobulins and viral vectors from crude starting material without requiring any clarification; cRUSH™: single-use continuous homogenizer for cell lysis